Industry: Machinery & Equipment
Published Date: 2026-03-06
Pages: 111 Pages
Report ld: 6028766
Request Sample
Customized Report
Pharmaceutical Dry Granulator Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 167
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 112 million in 2025 and is projected to reach US$ 167 million, growing at a CAGR of 6.0% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Dry Granulator cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical Dry Granulators, also known as roll press granulators, are machines used in the dry granulation process to produce uniform, high-quality granules for the pharmaceutical industry. These machines apply pressure to the powder, compacting it into dense sheets, which are then broken down into granules. The process is particularly advantageous for heat-sensitive or moisture-sensitive materials, as it does not require the use of liquids or heat, making it suitable for certain types of pharmaceutical formulations.
The Pharmaceutical Dry Granulators market is a segment within the pharmaceutical manufacturing equipment industry focused on the production and sale of roller compactors, also known as roll press granulators. These machines are used to create granules from dry powder, which is a critical step in the manufacturing of solid oral dosage forms such as tablets and capsules. The market is driven by the increasing demand for high-quality pharmaceuticals, the shift toward more efficient and cost-effective manufacturing processes, and technological advancements in the field of dry granulation. The global pharmaceutical industry is expanding rapidly due to rising health concerns, the aging population, and increased access to healthcare services. This has led to a higher demand for pharmaceuticals, including generics and over-the-counter (OTC) drugs, which in turn drives the need for efficient manufacturing equipment like roller compactors. Roller compacting offers a significant advantage over wet granulation because it eliminates the need for liquid binders and drying processes. This results in reduced production time, energy consumption, and cost, making it an attractive solution for pharmaceutical manufacturers. The growing availability of generic drugs worldwide, particularly in markets like North America, Asia-Pacific, and Europe, is increasing the demand for efficient, cost-effective granulation equipment. Roller compactors are particularly suited for manufacturing high-dose generic formulations, which require high-quality granules for consistency. Increasing regulatory scrutiny, especially from agencies like the FDA and EMA, is pushing manufacturers to adopt more efficient and precise production processes. Roller compactors help in achieving uniform granule size distribution, which is crucial for ensuring consistent tablet weight, uniformity, and drug release characteristics.
This report provides a comprehensive view of the global market for Pharmaceutical Dry Granulator, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Pharmaceutical Dry Granulator market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Dry Granulator.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Pharmaceutical Dry Granulator manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmaceutical Dry Granulator sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmaceutical Dry Granulator sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Dry Granulator Product Introduction
1.2 Global Pharmaceutical Dry Granulator Market Size Forecast
1.2.1 Global Pharmaceutical Dry Granulator Sales Value (2021–2032)
1.2.2 Global Pharmaceutical Dry Granulator Sales Volume (2021–2032)
1.2.3 Global Pharmaceutical Dry Granulator Sales Price (2021–2032)
1.3 Pharmaceutical Dry Granulator Market Trends & Drivers
1.3.1 Pharmaceutical Dry Granulator Industry Trends
1.3.2 Pharmaceutical Dry Granulator Market Drivers & Opportunities
1.3.3 Pharmaceutical Dry Granulator Market Challenges
1.3.4 Pharmaceutical Dry Granulator Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Dry Granulator Players Revenue Ranking (2025)
2.2 Global Pharmaceutical Dry Granulator Revenue by Company (2021–2026)
2.3 Global Pharmaceutical Dry Granulator Sales Volume Ranking of Players (2025)
2.4 Global Pharmaceutical Dry Granulator Sales Volume by Company (2021–2026)
2.5 Global Pharmaceutical Dry Granulator Average Price by Company (2021–2026)
2.6 Key Manufacturers Pharmaceutical Dry Granulator Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Dry Granulator Product Offerings
2.8 Key Manufacturers Start of Mass Production of Pharmaceutical Dry Granulator
2.9 Pharmaceutical Dry Granulator Market Competitive Analysis
2.9.1 Pharmaceutical Dry Granulator Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Dry Granulator Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Dry Granulator revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Pharmaceutical Dry Granulator Market Classification
3.1 Introduction by Type
3.1.1 Below 30Kg/Hour
3.1.2 30-200Kg/Hour
3.1.3 Above 200Kg/Hour
3.1.4 Global Pharmaceutical Dry Granulator Sales Value by Type
3.1.4.1 Global Pharmaceutical Dry Granulator Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Pharmaceutical Dry Granulator Sales Value, by Type (2021–2032)
3.1.4.3 Global Pharmaceutical Dry Granulator Sales Value, by Type (%), 2021–2032
3.1.5 Global Pharmaceutical Dry Granulator Sales Volume by Type
3.1.5.1 Global Pharmaceutical Dry Granulator Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Pharmaceutical Dry Granulator Sales Volume, by Type (2021–2032)
3.1.5.3 Global Pharmaceutical Dry Granulator Sales Volume, by Type (%), 2021–2032
3.1.6 Global Pharmaceutical Dry Granulator Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mid-size & Small Pharma Companies
4.1.2 Large Pharma Companies
4.2 Global Pharmaceutical Dry Granulator Sales Value by Application
4.2.1 Global Pharmaceutical Dry Granulator Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Pharmaceutical Dry Granulator Sales Value, by Application (2021–2032)
4.2.3 Global Pharmaceutical Dry Granulator Sales Value, by Application (%), 2021–2032
4.3 Global Pharmaceutical Dry Granulator Sales Volume by Application
4.3.1 Global Pharmaceutical Dry Granulator Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Pharmaceutical Dry Granulator Sales Volume, by Application (2021–2032)
4.3.3 Global Pharmaceutical Dry Granulator Sales Volume, by Application (%), 2021–2032
4.4 Global Pharmaceutical Dry Granulator Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Pharmaceutical Dry Granulator Sales Value by Region
5.1.1 Global Pharmaceutical Dry Granulator Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Pharmaceutical Dry Granulator Sales Value by Region (2021–2026)
5.1.3 Global Pharmaceutical Dry Granulator Sales Value by Region (2027–2032)
5.1.4 Global Pharmaceutical Dry Granulator Sales Value by Region (%), 2021–2032
5.2 Global Pharmaceutical Dry Granulator Sales Volume by Region
5.2.1 Global Pharmaceutical Dry Granulator Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Pharmaceutical Dry Granulator Sales Volume by Region (2021–2026)
5.2.3 Global Pharmaceutical Dry Granulator Sales Volume by Region (2027–2032)
5.2.4 Global Pharmaceutical Dry Granulator Sales Volume by Region (%), 2021–2032
5.3 Global Pharmaceutical Dry Granulator Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Pharmaceutical Dry Granulator Sales Value, 2021–2032
5.4.2 North America Pharmaceutical Dry Granulator Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Pharmaceutical Dry Granulator Sales Value, 2021–2032
5.5.2 Europe Pharmaceutical Dry Granulator Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Dry Granulator Sales Value, 2021–2032
5.6.2 Asia Pacific Pharmaceutical Dry Granulator Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Pharmaceutical Dry Granulator Sales Value, 2021–2032
5.7.2 South America Pharmaceutical Dry Granulator Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Dry Granulator Sales Value, 2021–2032
5.8.2 Middle East & Africa Pharmaceutical Dry Granulator Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Dry Granulator Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Pharmaceutical Dry Granulator Sales Value and Sales Volume
6.2.1 Key Countries/Regions Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.2.2 Key Countries/Regions Pharmaceutical Dry Granulator Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.3.2 United States Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.4.2 Europe Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.5.2 China Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.5.3 China Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.6.2 Japan Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.7.2 South Korea Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.8.2 Southeast Asia Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Pharmaceutical Dry Granulator Sales Value, 2021–2032
6.9.2 India Pharmaceutical Dry Granulator Sales Value by Type (%), 2025 vs 2032
6.9.3 India Pharmaceutical Dry Granulator Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Fitzpatrick
7.1.1 Fitzpatrick Company Information
7.1.2 Fitzpatrick Introduction and Business Overview
7.1.3 Fitzpatrick Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Fitzpatrick Pharmaceutical Dry Granulator Product Offerings
7.1.5 Fitzpatrick Recent Developments
7.2 Hosokawa
7.2.1 Hosokawa Company Information
7.2.2 Hosokawa Introduction and Business Overview
7.2.3 Hosokawa Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Hosokawa Pharmaceutical Dry Granulator Product Offerings
7.2.5 Hosokawa Recent Developments
7.3 Alexanderwerk
7.3.1 Alexanderwerk Company Information
7.3.2 Alexanderwerk Introduction and Business Overview
7.3.3 Alexanderwerk Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Alexanderwerk Pharmaceutical Dry Granulator Product Offerings
7.3.5 Alexanderwerk Recent Developments
7.4 Freund Corporation
7.4.1 Freund Corporation Company Information
7.4.2 Freund Corporation Introduction and Business Overview
7.4.3 Freund Corporation Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Freund Corporation Pharmaceutical Dry Granulator Product Offerings
7.4.5 Freund Corporation Recent Developments
7.5 Beijing LongliTech
7.5.1 Beijing LongliTech Company Information
7.5.2 Beijing LongliTech Introduction and Business Overview
7.5.3 Beijing LongliTech Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Beijing LongliTech Pharmaceutical Dry Granulator Product Offerings
7.5.5 Beijing LongliTech Recent Developments
7.6 GERTEIS
7.6.1 GERTEIS Company Information
7.6.2 GERTEIS Introduction and Business Overview
7.6.3 GERTEIS Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 GERTEIS Pharmaceutical Dry Granulator Product Offerings
7.6.5 GERTEIS Recent Developments
7.7 L.B. Bohle
7.7.1 L.B. Bohle Company Information
7.7.2 L.B. Bohle Introduction and Business Overview
7.7.3 L.B. Bohle Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 L.B. Bohle Pharmaceutical Dry Granulator Product Offerings
7.7.5 L.B. Bohle Recent Developments
7.8 Yenchen Machinery
7.8.1 Yenchen Machinery Company Information
7.8.2 Yenchen Machinery Introduction and Business Overview
7.8.3 Yenchen Machinery Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Yenchen Machinery Pharmaceutical Dry Granulator Product Offerings
7.8.5 Yenchen Machinery Recent Developments
7.9 WelchDry
7.9.1 WelchDry Company Information
7.9.2 WelchDry Introduction and Business Overview
7.9.3 WelchDry Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 WelchDry Pharmaceutical Dry Granulator Product Offerings
7.9.5 WelchDry Recent Developments
7.10 Cadmach
7.10.1 Cadmach Company Information
7.10.2 Cadmach Introduction and Business Overview
7.10.3 Cadmach Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Cadmach Pharmaceutical Dry Granulator Product Offerings
7.10.5 Cadmach Recent Developments
7.11 Canaan Technology
7.11.1 Canaan Technology Company Information
7.11.2 Canaan Technology Introduction and Business Overview
7.11.3 Canaan Technology Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Canaan Technology Pharmaceutical Dry Granulator Product Offerings
7.11.5 Canaan Technology Recent Developments
7.12 Bepex
7.12.1 Bepex Company Information
7.12.2 Bepex Introduction and Business Overview
7.12.3 Bepex Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Bepex Pharmaceutical Dry Granulator Product Offerings
7.12.5 Bepex Recent Developments
7.13 Prism Pharma Machinery
7.13.1 Prism Pharma Machinery Company Information
7.13.2 Prism Pharma Machinery Introduction and Business Overview
7.13.3 Prism Pharma Machinery Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Prism Pharma Machinery Pharmaceutical Dry Granulator Product Offerings
7.13.5 Prism Pharma Machinery Recent Developments
7.14 KEYUAN
7.14.1 KEYUAN Company Information
7.14.2 KEYUAN Introduction and Business Overview
7.14.3 KEYUAN Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 KEYUAN Pharmaceutical Dry Granulator Product Offerings
7.14.5 KEYUAN Recent Developments
7.15 KaiChuang Machinery
7.15.1 KaiChuang Machinery Company Information
7.15.2 KaiChuang Machinery Introduction and Business Overview
7.15.3 KaiChuang Machinery Pharmaceutical Dry Granulator Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 KaiChuang Machinery Pharmaceutical Dry Granulator Product Offerings
7.15.5 KaiChuang Machinery Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Dry Granulator Industrial Chain
8.2 Pharmaceutical Dry Granulator Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Pharmaceutical Dry Granulator Sales Model
8.5.2 Sales Channels
8.5.3 Pharmaceutical Dry Granulator Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 91
USD 4250.00
(Single User License)
The global Pharmaceutical Dry Granulator market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 167 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 142
USD 2900.00
(Single User License)
The global Pharmaceutical Dry Granulator market is projected to grow from US$ 105 million in 2024 to US$ 159 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 170
USD 4900.00
(Single User License)
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-02-09
Pages: 119
USD 3950.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-02-09
Pages: 105
USD 2900.00
(Single User License)
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 148
USD 3950.00
(Single User License)
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-04-12
Pages: 115
USD 4900.00
(Single User License)
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 110
USD 2900.00
(Single User License)
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published Date: 2024-01-08
Pages: 140
USD 3950.00
(Single User License)
The global Pharmaceutical Dry Granulator market size was US$ 112 million in 2025 and is forecast to reach a readjusted size of US$ 167 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 91
The global Pharmaceutical Dry Granulator market was valued at US$ 112 million in 2025 and is anticipated to reach US$ 167 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 142
The global Pharmaceutical Dry Granulator market is projected to grow from US$ 105 million in 2024 to US$ 159 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 170
The global Pharmaceutical Dry Granulator market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 159 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-02-09
Pages: 119
The global market for Pharmaceutical Dry Granulator was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-02-09
Pages: 105
The global market for Pharmaceutical Dry Granulator was estimated to be worth US$ 791 million in 2024 and is forecast to a readjusted size of US$ 1154 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 148
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-04-12
Pages: 115
The global Pharmaceutical Dry Granulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 110
A pharmaceutical dry granulator is a machine used in the pharmaceutical industry for dry granulation processes. Dry granulation involves the compaction of powder blends into granules without the use of liquid binders. This method is often employed when the addition of moisture is undesirable or when dealing with moisture-sensitive materials.
Published: 2024-01-08
Pages: 140
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now